Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: DanZ who wrote (4124)	4/21/2002 4:38:46 PM
From: Mike M	Respond to of 5582

Name change: siliconinvestor.com GUM TECH INTERNATIONAL INC - Corporate Name Change and Change in State of Incorporation Proposal New York, New York, Apr 15, 2002 (Market News Publishing via COMTEX) -- Shareholders To Vote On Changes At Annual Meeting In June Gum Tech International Inc., announced in conjunction with the Company's filing of its Preliminary Proxy Statement with the Securities and Exchange Commission, that it is asking shareholders to approve a proposal at its Annual Meeting to change the Company's name to Matrixx Initiatives, Inc. and to change the Company's state of incorporation from Utah to Delaware. The Annual Meeting currently is scheduled to be held on June 18, 2002 in Phoenix. "Changing the Company's name is the encompassing step that will represent definitively to our customers and our shareholders the significant operational and directional changes that Gum Tech has undergone in the last year," said Carl J. Johnson, president and chief executive officer of Gum Tech. "Because we no longer manufacture functional chewing gums, we feel it is appropriate to adopt a new name that is better suited to our future endeavors. Matrixx means a 'source or structure from which something else originates, develops or takes form,' which we feel represents well the changes the Company has gone through and the growth initiatives we will continue to pursue. "To achieve success and profitability, we understand that we will be continuously evolving to better serve our customers, vendors, and shareholders," Mr. Johnson continued. "In accordance with the definition of our new name, we expect our future products will be extensions of the intellectual property we currently own; and our goal of expanding distribution will reflect the knowledge and success gained from our current domestic distribution experience." Mr. Johnson also noted that by reincorporating in Delaware, the Company can benefit from a legal structure that management believes is more typical and better suited for a public company. If approved by the shareholders at the Annual Meeting, the name change and change of state of incorporation would become effective immediately after proper filings are made with state authorities, the SEC and the Nasdaq Stock Market. The Company has reserved with Nasdaq the trading symbol MTXX , which will become effective following completion of the name change. The Annual Meeting, scheduled for June 18, 2002 at 10:00 a.m. in Phoenix, Arizona, will be closed to the public. If you are not a shareholder as of April 19, 2002 but would like to attend the meeting, please contact William Hemelt, Chief Financial Officer, at 602-387-5353.

To: DanZ who wrote (4124)	4/21/2002 6:03:11 PM
From: Mike M	Read Replies (1) \| Respond to of 5582

By the way I put a few more memory lane posts together. Enjoy: Billy Bad ass: siliconinvestor.com <<Still absolutely no reason to cover. The stock will inevitably trade below 1 a share. I'm going to especially enjoy spending Mikey's, Danny's and ...oh...THIS guy's money:>> Hank: Message 15886394 <<5 coming soon...very soon>> Oh, and this one: Message 15510752 <<Did I call it or what?? Next stop $5! >> Hank loves to put charts up, wonder if he's seen this one: quote.yahoo.com Another of the great self proclaimed stock prognosticators, Anthony: Message 14990826 <<6 month price target of 50 -75 cents.. My positions are consistents(sic) with my postings as always.>>......Dec 10, 2000 Ain't life grand!

To: DanZ who wrote (4124)	4/22/2002 12:49:14 PM
From: Tatnic	Read Replies (1) \| Respond to of 5582

I'd say the stock has the momentum here to the upside. I have no position but if I were to take one, it would be long. My guess is you'll get your squeeze in the near-term.

To: DanZ who wrote (4124)	6/12/2002 1:03:57 PM
From: StockDung	Read Replies (1) \| Respond to of 5582

Daniel Zimmerman, Ph. D., Vice President of Research, Cellular Immunology 216.239.37.100 Cel-Sci: Hoax Release Carried on News Wire biz.yahoo.com Tuesday June 11, 7:58 pm Eastern Time Reuters Business Report By Andrea Orr PALO ALTO, Calif. (Reuters) - Biotechnology company Cel-Sci Corp. (AMEX:CVM - News) on Tuesday said it had become the victim of a hoax when a news wire carried a false press release stating that it was working on a potential cancer cure. The phony release did not cause a significant move in its stock and Cel-Sci said it appeared most investors had not believed the item, which ran for several hours Monday on the online news wire, Internet wire, and briefly on Yahoo! Inc's (NasdaqNM:YHOO - News) Finance Web site. Still, the incident raised fresh concerns over whether tighter safeguards had been put in place to prevent fictitious and potentially damaging news about publicly traded companies from being widely disseminated. Two years ago Internet Wire -- which carries corporate news releases as a source for other news outlets -- published a false release that about the earnings of data networking equipment maker Emulex Corp. (NasdaqNM:EMLX - News). That news was picked up by more mainstream news outlets including Bloomberg and Dow Jones and caused Emulex stock to fall by more than 50 percent. Aside from Yahoo Finance, no other news outlets picked up the Cel-Sci release from Internet Wire on Monday. Cel-Sci and Internet Wire both said Tuesday they had no information on the source of the phony press release, and were cooperating with the Securities and Exchange Commission in investigating the matter. The phony release, which was issued before the market opened on Monday, said that Cel-Sci had partnered with Takeda Chemical Industries Ltd. (Tokyo:4502.T - News) to commercialize a "potential cancer cure." "It would be nice if it were true, but there is no such deal," a Cel-Sci spokesman said. The spokesman said Cel-Sci, which is working on developing cancer treatments, has no relationship with Takeda and said it was never contacted by Internet Wire to verify the contents of the release before it was published. Internet Wire's Chief Executive Jim McGovern said it has safeguards in place to prevent false news from being published, but that those steps were not followed over the weekend, when the false news about Cel-Sci was received. Cel-Sci shares fell two cents on Tuesday to close at 30 cents per share, not far from their 52-week low of 27 cents. Its high point in the past year was $1.94.